According to our (Global Info Research) latest study, the global AI-assisted Embryo Selection System market size was valued at US$ 34.98 million in 2025 and is forecast to a readjusted size of US$ 119 million by 2032 with a CAGR of 18.5% during review period.
AI-assisted Embryo Selection Systems are intelligent embryo evaluation platforms designed for assisted reproductive technology and in vitro fertilization applications. These systems integrate time-lapse embryo imaging, microscopic image acquisition, computer vision, deep learning, and embryo morphokinetic analysis technologies to evaluate embryo development patterns, blastocyst morphology, cell division behavior, and potential implantation capability, thereby assisting embryology laboratories and fertility specialists in embryo selection and transfer decision-making.The major product forms include AI embryo scoring software, AI-integrated time-lapse incubation systems, cloud-based embryo analytics platforms, and digital embryology laboratory systems. Core capabilities involve embryo image recognition, morphokinetic analysis, multi-parameter data modeling, and clinical decision support, with primary applications in IVF clinics, fertility centers, and embryology laboratories.In 2025, the global AI-assisted Embryo Selection System industry recorded an average gross margin of approximately 58% to 78%. Average pricing for software subscription-based AI embryo assessment systems ranged from USD 5,000 to USD 50,000 per year, while AI-integrated time-lapse incubation systems typically ranged from USD 40,000 to USD 150,000 per unit.
AI-assisted Embryo Selection Systems are entering a rapid digitalization phase within the global assisted reproductive technology industry. The core value of the sector lies in improving embryo evaluation consistency, reducing subjective variation among embryologists, and increasing laboratory efficiency through artificial intelligence driven image analysis and morphokinetic modeling. Upstream supply chains mainly involve optical imaging modules, microscopy systems, computing infrastructure, cloud platforms, and embryo data resources. Midstream activities focus on AI embryo assessment software, time lapse incubation systems, and digital embryology laboratory platforms, while downstream demand is concentrated in IVF clinics, fertility centers, and advanced reproductive medicine institutions. Due to the high barriers associated with clinical validation, embryo outcome databases, and regulatory compliance, the number of globally commercialized suppliers remains relatively limited, resulting in a highly concentrated competitive landscape.
The industry is gradually transitioning from research oriented deployment toward broader clinical commercialization as fertility centers increasingly seek standardized embryo grading and automated laboratory workflows. Time lapse embryo imaging, cloud based embryo analytics, and deep learning based embryo ranking models are becoming the primary technological development directions. Several suppliers are extending their platforms toward implantation prediction, multi parameter embryo evaluation, and integrated digital IVF laboratory ecosystems. Companies from Europe, Israel, and North America currently maintain advantages in AI model development, global IVF clinic penetration, and large scale embryology databases, while Japanese suppliers remain stronger in laboratory hardware, optical systems, and incubation equipment. China and South Korea are showing rising activity through hospital driven AI embryo projects and regional deployment initiatives.
Supportive fertility policies, delayed parenthood trends, and rising global infertility rates are expected to sustain long term market expansion. Governments in multiple regions are increasing attention toward reproductive healthcare accessibility and digital medical infrastructure, which indirectly supports AI deployment in IVF laboratories. At the same time, the industry continues to face challenges related to fragmented clinical data standards, lengthy validation cycles, and tightening medical AI regulatory frameworks. Future competition is expected to focus increasingly on data scale, real world clinical evidence, AI model generalization capability, and the integration of software platforms with automated embryology laboratory systems.
This report is a detailed and comprehensive analysis for global AI-assisted Embryo Selection System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Deployment Mode and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI-assisted Embryo Selection System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global AI-assisted Embryo Selection System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global AI-assisted Embryo Selection System market size and forecasts, by Deployment Mode and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global AI-assisted Embryo Selection System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-assisted Embryo Selection System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-assisted Embryo Selection System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vitrolife Group, Fairtility, AIVF, Life Whisperer, Alife Health, MIM Fertility, Hamilton Thorne, Esco Medical, Genea Biomedx, ASTEC Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
AI-assisted Embryo Selection System market is split by Deployment Mode and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Deployment Mode, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Deployment Mode
On-premise Systems
Cloud-based Platforms
Hybrid Deployment Systems
Others
Market segment by Technology Route
Time-lapse Imaging-based AI
Static Image-based AI
Morphokinetic Parameter-based AI
Multi-modal Embryo Assessment AI
Others
Market segment by Application
IVF Clinics
Fertility Centers
Academic and Research Institutions
Others
Major players covered
Vitrolife Group
Fairtility
AIVF
Life Whisperer
Alife Health
MIM Fertility
Hamilton Thorne
Esco Medical
Genea Biomedx
ASTEC Co., Ltd.
K-Systems
Shengshengyi (Beijing) Technology Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe AI-assisted Embryo Selection System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of AI-assisted Embryo Selection System, with price, sales quantity, revenue, and global market share of AI-assisted Embryo Selection System from 2021 to 2026.
Chapter 3, the AI-assisted Embryo Selection System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AI-assisted Embryo Selection System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Deployment Mode and by Application, with sales market share and growth rate by Deployment Mode, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and AI-assisted Embryo Selection System market forecast, by regions, by Deployment Mode, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of AI-assisted Embryo Selection System.
Chapter 14 and 15, to describe AI-assisted Embryo Selection System sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on AI-assisted Embryo Selection System. Industry analysis & Market Report on AI-assisted Embryo Selection System is a syndicated market report, published as Global AI-assisted Embryo Selection System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AI-assisted Embryo Selection System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.